Patient Guide: A Safety and Efficacy Study Evaluating CTX001 in Subjects With Severe Sickle Cell Disease

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 17 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT03745287
Status: COMPLETED
Condition: Sickle Cell Disease, Hematological Diseases, Hemoglobinopathies
Phase: PHASE2, PHASE3

Find a Study Location Near You

This study is available at 17 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • Palo Alto, California
  • Chicago, Illinois
  • Chicago, Illinois
  • • And 14 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily